Search results for abx831316

Lumretuzumab, Abbexa, abx831316

Lumretuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB3, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Lumretuzumab has been used in trials studying the treatment of Neoplasms, Breast Cancer, Squamous Non-Small Cell Lung Cancer, and Non-Squamous Non-Small Cell Lung Cancer.